Shares of Kohl’s Corporation (NYSE:KSS – Get Free Report) have been given a consensus recommendation of “Reduce” by the sixteen research firms that are presently covering the firm, MarketBeat reports. Seven investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, one has assigned a buy rating and one […]

Shares of PagSeguro Digital Ltd. (NYSE:PAGS – Get Free Report) have earned a consensus rating of “Hold” from the eight research firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the […]

Shares of Cemex S.A.B. de C.V. (NYSE:CX – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twelve brokerages that are covering the stock, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average […]

Shares of Orion S.A. (NYSE:OEC – Get Free Report) have been given an average recommendation of “Strong Sell” by the five ratings firms that are covering the firm, MarketBeat reports. Three analysts have rated the stock with a sell rating and two have issued a hold rating on the company. The average 1 year price […]

PACS Group, Inc. (NYSE:PACS – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven research firms that are presently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month target […]

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) has been given a consensus rating of “Moderate Buy” by the thirteen research firms that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average 1 […]

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report)‘s stock had its “neutral” rating reaffirmed by analysts at Wedbush in a note issued to investors on Monday,Benzinga reports. They presently have a $12.00 target price on the stock. Wedbush’s price target would suggest a potential downside of 11.03% from the company’s previous close. Several other research firms […]

Shares of Casella Waste Systems, Inc. (NASDAQ:CWST – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twelve brokerages that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, one has assigned a hold rating, eight have given a buy rating and […]

Lyell Immunopharma (NASDAQ:LYEL – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by stock analysts at Citizens Jmp in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $34.00 price objective on the stock. Citizens Jmp’s target price would suggest a potential upside of 151.57% from the […]

United Therapeutics (NASDAQ:UTHR – Get Free Report) and Indaptus Therapeutics (NASDAQ:INDP – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, analyst recommendations, dividends, earnings and institutional ownership. Risk and Volatility United Therapeutics has a beta […]